Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells-an in‑vitro study

Head Face Med. 2023 Aug 18;19(1):35. doi: 10.1186/s13005-023-00386-x.
No abstract available

Publication types

  • Published Erratum